DE69120463T2 - Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit - Google Patents

Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit

Info

Publication number
DE69120463T2
DE69120463T2 DE69120463T DE69120463T DE69120463T2 DE 69120463 T2 DE69120463 T2 DE 69120463T2 DE 69120463 T DE69120463 T DE 69120463T DE 69120463 T DE69120463 T DE 69120463T DE 69120463 T2 DE69120463 T2 DE 69120463T2
Authority
DE
Germany
Prior art keywords
procedure
detection
determine blood
erythrocyte agglutination
blood tolerance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69120463T
Other languages
English (en)
Other versions
DE69120463D1 (de
Inventor
Lucienne Nee Wartel Mannessier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Fondation Pour La Recherche Diagnostiques de la
Original Assignee
CENTRE REGIONAL DE TRANSFUSION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9395144&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69120463(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CENTRE REGIONAL DE TRANSFUSION filed Critical CENTRE REGIONAL DE TRANSFUSION
Publication of DE69120463D1 publication Critical patent/DE69120463D1/de
Application granted granted Critical
Publication of DE69120463T2 publication Critical patent/DE69120463T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69120463T 1990-03-27 1991-03-18 Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit Expired - Lifetime DE69120463T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9003873A FR2660437B1 (fr) 1990-03-27 1990-03-27 Procede de mise en evidence d'agglutination erythrocytaire destine aux analyses de comptabilites sanguines.

Publications (2)

Publication Number Publication Date
DE69120463D1 DE69120463D1 (de) 1996-08-01
DE69120463T2 true DE69120463T2 (de) 1997-01-23

Family

ID=9395144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120463T Expired - Lifetime DE69120463T2 (de) 1990-03-27 1991-03-18 Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit

Country Status (9)

Country Link
EP (1) EP0454509B1 (de)
AT (1) ATE139847T1 (de)
DE (1) DE69120463T2 (de)
DK (1) DK0454509T3 (de)
ES (1) ES2089160T3 (de)
FR (1) FR2660437B1 (de)
GR (1) GR3020960T3 (de)
PT (1) PT97151B (de)
SG (1) SG47462A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002306B (el) * 1990-11-09 1996-05-08 Ortho Diagnostic Systems Inc. Αναλυση και διαταξη συγκολλησεως στηλης.
FR2697633B1 (fr) * 1992-10-21 1995-01-20 Pasteur Sanofi Diagnostics Procédé d'immunodiagnostic en matrice poreuse avec particules sensibilisées et dispositif pour sa mise en Óoeuvre.
US5552064A (en) * 1993-02-26 1996-09-03 Ortho Diagnostic Systems, Inc. Column agglutination assay and device using biphasic centrifugation
FR2719122B1 (fr) * 1994-04-22 1996-07-12 Scibiex Sarl Dispositif et procédé d'analyse immunologique.
NL9400777A (nl) * 1994-05-10 1995-12-01 Stichting Centraal Lab Vaste-fase filtratiemethode voor antigeen- en antistofbepalingen in de bloedgroepserologie, en testkit.
US5905028A (en) * 1994-05-17 1999-05-18 Gamma Biologicals, Inc. Method and apparatus useful for detecting bloodgroup antigens and antibodies
FR2732037B1 (fr) * 1995-03-20 1997-05-30 Dbv Procede de detection de microorganismes par separation et culture sur un systeme gelifie, systeme gelifie et necessaire de dosage pour mettre en oeuvre ce procede, utilisation en microbiologie
EP0805354A1 (de) * 1996-04-29 1997-11-05 Matthew R. Dr. Pincus Direkter Nachweis von unerwarteten Alloantikörper in Seren von prospectiven Transfusionsempfängern unter Verwendung eines neuen Hämoglutinationstestes
NL1003570C2 (nl) * 1996-07-11 1998-01-15 Stichting Centraal Lab Methode voor antigeen- en antistofbepaling in de bloedgroepserologie.
ES2126521B1 (es) * 1997-06-05 1999-11-16 Transfusion De La Comunidad Va Metodo para la deteccion de antigenos presentes en la membrana de hematies, propios o acoplados y de anticuerpos irregulares en muestras de suero.
US20070100557A1 (en) * 2005-10-24 2007-05-03 Yi Zhang Selection of genotyped transfusion donors by cross-matching to genotyped recipients
EP1840572A1 (de) * 2006-03-30 2007-10-03 Stiftung Für Diagnostische Forschung System für den verbesserten Nachweis von Antikörpern gegen Erythrozytenantigene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039195B1 (de) * 1980-04-28 1986-06-18 Montefiore Hospital and Medical Center Verfahren zur Feststellung von Antikörpern
GB2117514B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Polyvalent antiglobulin reagent
FR2577321B1 (fr) * 1985-02-08 1989-04-28 Lapierre Yves Dispositif et procede de mise en evidence d'agglutinats erythrocytaires
JPH087215B2 (ja) * 1987-08-24 1996-01-29 シュティフツング・フュア・ディアグノスティッシュ・フォルシュンク 抗原および／又は抗体の検出方法および検出用の試験キット

Also Published As

Publication number Publication date
DE69120463D1 (de) 1996-08-01
PT97151A (pt) 1991-11-29
EP0454509A2 (de) 1991-10-30
ES2089160T3 (es) 1996-10-01
PT97151B (pt) 1999-12-31
EP0454509B1 (de) 1996-06-26
ATE139847T1 (de) 1996-07-15
FR2660437B1 (fr) 1993-11-19
DK0454509T3 (da) 1996-11-04
EP0454509A3 (de) 1991-11-06
FR2660437A1 (fr) 1991-10-04
SG47462A1 (en) 1998-04-17
GR3020960T3 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
CA1195925A (en) Method for assaying antigen-antibody reactions and reagent therefor
DE69120463T2 (de) Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit
ATE75041T1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zellleukozytenantik¯rpern.
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
Tovey et al. Standardization of allergens: qualitative definition of house dust mite extracts following electroblotting and detection of components with antibody and lectin probes
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ATE129075T1 (de) Wässerige suspension für diagnostischen test.
DK0462115T3 (da) Diagnostisk proteinmarkør for blærecancer
DE3780446D1 (de) Verfahren zur feststellung von schwangerschaftsstoerungen.
ATE60445T1 (de) Verfahren und testelement zum auffinden von zellaesionen.
ATE79955T1 (de) Verfahren und testsatz zur diagnose von pflanzenkrankheiten.
EP0762121A1 (de) Antigen für Enzymimmuntest und Verfahren zur Messung von erythrozytären Antikörpern
CA1049405A (en) Test method to determine pulmonary embolism
Mischler et al. Immunological identification of human seminal stains
Williams et al. Reactions of Antibodies with Soluble Antigens: Methods in Immunology and Immunochemistry, Vol. 3
Coonrod et al. Immunoelectrophoresis for detection of polysaccharides in immune complexes
Strony et al. Demonstration of cerebrospinal fluid oligoclonal banding in neurologic diseases by agarose gel electrophoresis and immunofixation
WO1998039656A1 (en) Method for detecting the presence of an immunologically reactive molecule in a sample
SU1175442A1 (ru) Способ диагностики гипоксии мозга у новорожденных
Shapshak et al. Concentration of cerebrospinal fluid does not affect immunoglobulin G oligoclonal banding patterns
RU1813213C (ru) Способ оценки иммунологического статуса рабочих, св занных с вредными летучими веществами
JP2704760B2 (ja) 凝集抗体
Plan et al. Comparison between agarose gel electrophoresis (Panagel) of cerebrospinal fluid with silver staining, and polyacrylamide disc gel electrophoresis for demonstration of the oligoclonal pattern in neurological disorders
Obernolte Isolation, Purification, and Characterization of a Human Heart-specific Protein
Raszka et al. Modification of the method of radial haemolysis in gel for screening detection of antibodies against rubella with an unequivocal results.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: LA FONDATION POUR LA RECHERCHE DIAGNOSTIQUES DE LA